RegMedNet's 2023 top content of the year featured an article about the UK trial of the CellQualia Intelligent Cell Processing System.
2024.05.13
RegMedNet is a community site for regenerative medicine and advanced medicine operated by Taylor & Francis Group. （https://www.regmednet.com/about/）
An April 3, 2023, article on the site entitled “Developing cell therapies with a stem cell robot” described that the UK Stem Cell Bank, a part of the UK's Medicines and Healthcare products Regulatory Agency (MHRA), introduced CellQualiaTM Intelligent Cell Processing (ICP) System for evaluation.
（https://www.regmednet.com/developing-cell-therapies-with-a-stem-cell-robot/）
This article was picked up as an industry topic followed a press release from the MHRA that appeared on the UK government website on March 16, 2023.
In addition, “RegMedNet's 2023 remix: top content of the year”, published on December 19, 2023, named our instrument's evaluation test at the UK Stem Cell Bank among the site's top 10 articles of 2023.
https://www.regmednet.com/regmednets-2023-remix-top-content-of-the-year/
We believe that this nomination represents the expectation to CellQualiaTM ICP System that the system contributes to improving manufacturing efficiency and stabilizing quality in the production of stem cells, which are the raw materials for cellular medicine manufacturing, and the spread of regenerative medicine will be accelerated by it. We will continue to strive to popularize the equipment so that various customers can stably manufacture high-quality cells.